Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis

BACKGROUND: Serum sphingolipids are widely involved in the development of hepatocellular carcinoma (HCC). We investigated the serum sphingolipid profile in patients with HCC or cirrhosis and explored the potential diagnostic efficiency of serum sphingolipid metabolites which may be helpful in differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yingying, Tie, Cai, Wang, Yang, Bian, Dandan, Liu, Mei, Wang, Ting, Ren, Yan, Liu, Shuang, Bai, Li, Chen, Yu, Duan, Zhongping, Zheng, Sujun, Zhang, Jinlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506152/
https://www.ncbi.nlm.nih.gov/pubmed/33014866
http://dx.doi.org/10.3389/fonc.2020.01759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506152/
https://www.ncbi.nlm.nih.gov/pubmed/33014866
http://dx.doi.org/10.3389/fonc.2020.01759

Ejemplares similares